FDA approves ocular steroid for post-surgical pain and inflammation

Inflammation Post Cataract Surgery - Episode 13Подробнее

Clinical Progress of Ocular Therapeutix’s DextenzaПодробнее

Ocular Therapeutix Waiting for Word from FDAПодробнее

FDA Approves NDA for PROLENSA for Treatment after Cataract SurgeryПодробнее

Managing Inflammation After Cataract Surgery - Episode 55Подробнее

Glancing Back at 2018 FDA Approvals In EyecareПодробнее

EyePoint: Transforms Into Commercial-Stage Organization with Dexycu and YutiqПодробнее

UPDATED-Sumitra Khandelwal, MD-Steroid use in treating ocular inflammationПодробнее

How do you utilize steroids to address ocular surface inflammation when initiating therapy?Подробнее

FDA Warns Popular Nerve Pain Drugs Gabapentin, Pregabalin Linked To Serious Breathing Problems & DeaПодробнее

Drs Rapuano and Nagra of Wills Eye Hospital discuss the FDA Approval of XiidraПодробнее

New Eye Drops Improve Age-Rlated Blurry VisionПодробнее

FDA Approves New Cancer Drug That's Already Showing PromiseПодробнее

How do you utilize steroids during induction to address ocular surface inflammation?Подробнее

Justin Schweitzer, OD | Ocular Inflammation Harnesses InflammaDry for Comprehensive Eye EvaluationsПодробнее

FDA approves new wrinkle fighterПодробнее

Tracy Schroeder Swartz, OD, MS, FAAO - Treatment of Ocular InflammationПодробнее

CataractCoach 1394: post-op day one complications after cataract surgeryПодробнее

Eye medications after cataract surgery, routine drops - A State of Sight #129Подробнее